DEVICE FOR OLIGONUCLEOTIDE ASSAY AND METHOD OF PREPARATION THEREOF

Abstract: A device is described for use in an oligonucleotide assay having predetermined portions of its surface treated for covalent binding. The device comprises: a) a receptor material disposed upon and covalently bound to the treated predetermined portions, the receptor material partially covering the treated portions and leaving uncovered interstices therebetween of the surface treated for covalent binding; and, b) masking means for masking the uncovered interstices of surface treated for covalent binding, the masking means substantially covering and bound to the uncovered interstices without interfering with the receptor material.

Description: - 1 - Title DEVICE FOR OLIGONUCLEOTIDE ASSAY AND METHOD OF PREPARATION THEREOF BACKGROUND OF THE INVENTION Field of the Invention. This invention relates to a device for use in the liquid phase quantitative analysis of oligonucleotides, such as deoxyribonucleic acid (DNA) and the method of forming the device. The invention also relates to a DNA assay kit that includes the device and to the method of obtaining quantita- tive analyses by the use thereof. More particularly, the analysis, in its preferred form, entails using colorimetric techniques. 2. Information Disclosure Statement, In the past, the technology for liquid phase quantita¬ tive analysis of oligonucleotides, particularly DNA, has not been available. Most quantitative analysis of DNA has been in the solid phase either through column chromatography or filter media techniques such as the Downs and Wilfinger Method. [Ref. Anal. Biochem. , 131, pp. 538-47 (1983).] DNA molecules are double stranded helical molecules. Each strand consists of sequences of nucleic acids held together by phosphate linkages. The sequence of nucleotides determines the function of the molecule. The two strands are held together by base pair complementary binding, and each strand of DNA binds only to its complement. By using the proper conditions of pH and temperature, it is possible to split the double strand into two complementary single strands. The single stranded DNA can be used to identify the source of a particular material by comparing the sequence of nucleic acids with the sequence from known - 2 - sources. Alternatively, the presence of a particular DNA can be detected by attempting to hybridize it to a complementary DNA of known sequence. Most DNA analysis is carried out by hybridization studies on a membrane surface. In this technique, the DNA to be identified is immobilized onto the surface of a nitro cellulose membrane by spotting a drop of solution containing the single stranded DNA onto the membrane, sealing the membrane into a plastic bag and incubating overnight at elevated temperatures. Then a solution of the complementary DNA which has been tagged with radioactive I 125 or P 32 is placed onto the spot and incubated again to allow hybridization to take place. After incubation, the spot is washed carefully to remove any unbound material, and then the presence of radioactivity is measured. If the unknown strand and the radio labelled strand are complementary, radioactivity will be retained. The success of the procedure requires that the binding conditions and the hybridization condition be different enough to prevent any direct binding of the labelled DNA to the membrane. This procedure is at best a semiquantitative procedure, and in most cases is only qualitative because the area of the spot is not confined and well defined. In preparing for this application, a search of the Chemical Abstracts was conducted. This search uncovered the following: PCT Int'l. Appl. - WO 90 07582, July 12, 1990, U.S. Appl. - 293,895; PCT Int'l. Appl. - WO 88 02785, U.S. Appl. - 919,201; and, an article by J. Lundeberg et al, entitled "Rapid Colorimetric Detection of In Vitro Amplified DNA Sequences" from DNA And Cell Biology, Vol- 9, No. 4, 1990. These references are of interest only. In further preparation, a pre-examination patentability search was performed, which search reviewed several - 3 - subclasses of Class 935, especially Subclasses 78 and 86. The search uncovered the following patents: US 4,767,699 - C.P.H. Vary et al. (Allied Corp.) The probe described contains biotin, and the hybridized complex may be separated therefrom using a streptavidin- bound matrix. The probe therefrom is bound covalently or otherwise to a solid support: this may include binding with a biotin-avidin or streptavidin bridge. US 4,889.798 - E. Rabbani fEnzo Biochem Inc., This patent describes a heterologous detection system for a biotinylated probe. The probe can be fixed to nitrocellulose paper, nylon, etc. US 4,751.177 & US 4,797.355 - Y. Stabinsky (Amgen Inc.) A polynucleotide is synthesized on a solid support such as glass, and is then used for binding polynucleotide probes. (The glass described is amine-functionalized with a silane derivative). US 4 ,994 ,373 - J.G. Stayrianopoulos et al. (Enzo Biochem) Polynucleotide sequences to a glass support, which may have wells, e.g. by using gamma-aminoproply-triethoxysilane. Biotin-avidin may be used to bond a signalling moiety to the probe. US 4,886,741 - D.E. Schwartz (Microprobe Corp.) Enzymatic detection of hybridized probes using biotin w an enzyme conjugated with avidin or streptavidin is discussed. - t — US 4,888,274 - CM. Haddinσ et al. CYale University) Biotinylated probes and target purification by streptavidin chromatography are described in examples. US 4.925,785 - C.N.J. Wang et al. fBiotechnics Diag. Inc.) Hybridization methods using a solid support bound to a nucleic acid sequence which can bond to a probe. In a heterogenous sandwich assay, a polymer-bound probe is restricted to a very small area on the support, to increase signal intensity from the label. US 4.908,307 - K. D. Rodland et al. Variants of conventional hybridization of DNA bound to nitrocellulose or nylon membranes are disclosed. Labeling by biotinylated adenosine polymer and detection using streptavidin and biotinylated enzyme are mentioned. These patents are a typical reflection of the state-of- the-art of genetic engineering assay procedures, but do not generally reflect the application of the same to liquid phase systems or to quantitative analysis of oligo- nucleotides. These patents do not provide a means for nor do they teach toward forming or using a masked receptor as described hereinbelow or for the method of use thereof. Further, the typical reflection of the state-of-the-art of immunoassay procedure, specifically as to covalent binding, is attained by reference to U. S. Patent 4,778,767. There it is noted that Shekarchi, et al., J. Clin. Microbiology 16(6), 1012-1018 (December, 1982) discloses an immunoassay procedure wherein an immunoreagent is immobilized on a small stick, i.e., "microstick", for easy manipulation of the reagent and the immunocomplex. While a number of materials were investigated for use in such microsticks, including stainless steel, nylon, polycarbonate, polystyrene and polytetrafluorolethylene (PTFE), it was found that the PTFE, cleaned by the conventional procedure of rinsing with 6N HC1, absorbed very little of the immunoreagent as compared with the other materials and could not be used as a base for the immuoreagent until it had been coated with polycarbonate or nitrocellulose. The previously referenced patent further cites German Offenlegungsschrift No. 32 00 822, published July 21, 1983, which discloses a method for activating the surface of PTFE articles, in order to bond immunoreagents covalently, by contacting the PTFE surface with an ammoniacal solution of sodium, followed by treatment with carbodiimide. It indicates that the process was apparently attempted because it was found that adsorption of the immunoreagent on PTFE was unsatisfactory, and also that there is some question whether the procedure of this German application actually can immobilize a useful amount of immunoreagent on PTFE. As are described in more detail below, other procedures for surface treatment of polystyrene have been adopted resulting in the commercial availability of polystyrene covalent binding plates. In the field of oligonucleotide assays, the need for liquid phase, quantitative analysis has been a long-standing problem which is addressed by this invention. SUMMARY In general terms, the invention disclosed hereby includes in the apparatus embodiment thereof, an assay device for quantitative liquid-phase analysis of an oligonucleotide, such as deoxyribonucleic acid (DNA) that consists of a plastic base, typically polystyrene; covalent binding means for covalent bonding of receptor materials to the surface of the base utilized in the assay, said means being a surface modification to produce covalent binding sites integral with the plastic base material; a receptor agent (avidin, streptavidin, monoclonal antibody directed . - 6 - against sulfonated DNA, etc.) forming sites thereof by bonding to portions of said binding means and forming interstices therebetween; and, a mask of, for example, bovine serum albumin with salmon sperm DNA, covering the exposed interstitial portions of the covalent binding me ans; whereby, upon a presensitized DNA probe with the DNA material-to-be-assayed being adhered thereto, the quantity of DNA is determinable by colorimetric, fluorescent or radiometric means. BRIEF DESCRIPTION OF THE DRAWINGS In the following drawings, the same parts in the various views are afforded the same reference designators. FIG. 1 is a schematic representation of the assay plate of the present invention; FIG. 2 is a schematic representation of the assay device shown in a microwell format, said schematic representation using symbols explained therein; and, FIG. 3 is a schematic representation of the enzyme linked oligonucleotide assay of the present invention. DESCRIPTION OF THE PREFERRED EMBODIMENT In general terms and in the preferred form of the disclosure, an enzyme-linked oligonucleotide assay is described. This assay, generally referred to by the assignee's trademark "ELONA", provides a new microwell-plate based assay for quantitative determination of the concentration of a specific target DNA. The process is based in part on covalent bonding technology, referred to in the Information Disclosure Statement, and in part on the modification of plastic surfaces as presently commercially available. Although the Xenopore plate is preferred, as will be seen in more detail below, there are several - 7 - alternatives available to overcome the problem of DNA not adhering passively to plastic surfaces. In the assay at hand, the covalent binding property of the plate enables the production of receptor sites. In the description which follows, a device is provided for assay purposes and a general regimen of the use of the device in a liquid phase quantitative analysis is provided. This regimen is first described in terms of a probe sensitization mechanism and of the binding of the sensitized probe to the device of this invention. Then, the material- to-be-assayed or target DNA is introduced onto the device, and, for colorimetric processing, a reaction is initiated and arrested with the optical density reading providing an equivalent quantification of the target DNA. Although the text hereof is prepared for one skilled in analytical work of this nature, from time-to-time definitions are provided to lend clarity to the text and the claims appended hereto. Referring now to FIG. 1, the assay device is shown and is referred to generally by the reference numeral 10. Although in the description of the best mode of this invention, a microtiter or microwell plate format is shown. The assay device is described in terms of a nonformatted container or plate. A plastic base or plate 12 is constructed to contain a surface layer 14 on a predetermined portion thereof which has been treated for covalent binding. Such treated plates are commercially available from Costar, Inc., Cambridge, MA - Product Nos. 3390 and 3490; Nunc A/S, Roskilde, Denmark - Product No. 478042; and Xenopore Corp., Saddle Brook, NJ - Xenobind Plate, Model No. XPL 050 00. Although the bases or plates are most commonly manufactured from polystyrene, other materials such as nylon, polycarbonate, polymethylmethacrylate, polytetrafluoroethylene (PTFE) and polyurethane may be used. In the preferred format employed herein, enzymatic color reactions are used to - 8 - quantitate the oligonucleotide present in the analyte, and polystyrene has shown to be the material of choice, especially with the plate readers employed. Further, while the microtiter or microwell plates are discussed as preferred, the receptor binding and masking thereof, described in detail hereinbelow, can be constructed on a base of polystyrene beads, including engineered particulate beads having channeling therewithin for enhanced high performance liquid chromatography, such beads are described in the patent to F. E. Regnier et al, U.S. Patent 5,019,270. A receptor 16 is next bound to the surface layer 14 by the method described hereinbelow. The receptor 16 is a glycoprotein typically selected from avidin, streptavidin and a monoclonal antibody against sulfonated DNA. After binding of the receptor 16, the plate 12 is washed to remove any unbound material. At this stage of construction, the receptor material 16 is disposed upon and covalently bound to the treated predetermined portions of surface layer 14 and, among the deposited receptor material 16, interstices or interstitial areas 18 of the surface layer 14 treated for covalent binding remains uncovered. Next a mask material is applied to cover the interstitial areas 18 and, in the pref erred form, a coarse and a fine coat are applied or, in other terms, a prime and a finish coat. It is not inconceivable that a "one-shot" application of mask material may be used. In the best mode of practicing this invention, proteinaceous masks are constructed. A primary layer or mask 20 is constructed to cover substantially the interstitial areas 18. Here the preference is for bovine serum albumin which, after removing the excess thereof, being a coarse material is found to yet leave uncovered extremely small interstices or interstitial areas 22. So as to preclude covalent attraction of the analyte, these small interstitial areas 22 also need to be covered. The covering of the interstitial areas 18 is performed with a material which does not interfere with the functioning of the receptor 16. A secondary layer or mask 24 is constructed to cover substantially e interstitial areas 22. Here the - 9 - preference is for salmon sperm DNA which, after removing the excess thereof, is found to seal completely the yet uncovered surface so that no surface treated for covalent binding remains exposed. The covering of the small interstitial areas 22 is also performed with a material which does not interfere with the receptor 16. With the above-described assay device, it is seen that the basis of the invention is the ability to covalently attach streptavidin or the receptor of choice to the surface of microtiter plates. While the covalent attachment is most conveniently done by incubation of a solution of streptavidin in carbonate buffer with a Xenobind plate, a microtiter plate having covalent attachment sites on its surface, as indicated, any other compatible covalent binding vehicle may be used. With the assay plate prepared, the use thereof for an oligonucleotide assay is next described. In the description of the procedures which follow there is no claim made to the hybridization aspects thereof as all of the underlying technology is well within the state-of-the-art. The known complementary oligonucleotides to the oligonucleotide to be detected (hereinafter DNA, by way of example) is reacted with biotin to produce a DNA molecule with biotin binding sites within it. These biotin binding sites are capable of reacting with streptavidin to form a strong stable bond. In the most preferred procedure, only one biotin molecule is attached to each DNA molecule, but this is not an essential part of the process. To carry out the detection, the biotinylated complement is treated in either of two ways: In the first way, the biotinylated DNA complement is mixed v/ith the DNA to be identified and hybridization takes place. The solution is then placed in the wells of a streptavidin coated plate where competitive binding takes place, with the hybridized and non-hybridized biotin containing DNA bind in proportion to their relative concentrations in solution. - 10 - In the second way, the biotinylated DNA is placed into the streptavidin coated well and binds to the streptavidin- The DNA to be identified is then added to the well where hybridization takes place. This procedure has the disadvantage of being slower than the first procedure since the DNA complement is partly immobilized but avoids the concentration limitation of the competitive assays. In either case, after hybridization and binding is completed, and unbound material washed out of the wells, a second, tagged, complement to a different section of the DNA to be identified, is added, and hybridization again occurs. The known DNA fragments in each case are shorter than the DNA to be identified, but long enough to be specific for the molecule to be identified. Any one of a number of tags can be used for identification. If the first probe has only single biotin molecule, such that there are no free biotins, then the second probe can also be biotinylated. Then an avidin- alkaline phosphatase complex can be bound to be immobilized material and the color developed with an appropriate substrate. The intensity of color depends on the quantity of DNA (the target) present in the solutions and appropriate calibration produces quantitative results. Another detection system uses a sulfonated DNA as the second probe and a monoclonal antibody specific for sulfonated DNA is added, followed by an alkaline phosphatase tagged polyclonal anti-antibody. A third detection system involves tagging the DNA with a luminous material which is activated by a substrate and can be quantitated. - 11 - Detailed Procedure In the detailed procedures which follow, numerous buffers are used at various stages of the assay. It is within the state-of-the-art to substitute variations of the buffers without changing the invention hereof , and thus it is indicated that a "suitable buffer" may be used. For purposes of this disclosure, a "suitable buffer" for the covalent binding step is defined as a buffer in which the pH thereof is above the isoelectric point of the protein being bound. A "suitable buffer" for the hybridization step is any buffer in which the DNA retains its ability to hybri¬ dize. The buffers are referred to by their standard abbre¬ viations as given in the "Information for Contributors" in The Journal of Immunology: the Official Journal of The American Association of Immunologists. The hybridization and immunoassay procedures referred to in this disclosure are described in detail in the book. Biochemistry, 3rd edition, by Lubert Stryker (W. H. Freeman and Company, New York, 1990). It is also noted that various enzyme conju¬ gates can be linked to the second polynucleotide probe according to the parameters at hand. Some of the commerci¬ ally available enzyme systems include: Avidin Related Enzyme Systems Avidin Unit Definition: One unit will bind 1.0 μg of d-biotin. Avidin-Alkaline Phosphatase Labeled (Sigma A2527) Labeled with Type VII alkaline phosphatase, lyophilized powder containing approx. 35% protein (Warburg-Christian); balance primarily Tris aspartate buffer with trace magnesium acetate and zinc sulfate. Contains 1-3 moles of alkaline phosphatase per mole of avidin. Actual content given on label. - 12 - Avidin Activity: 2-6 units per mg protein. Alkaline Phosphatase Activity: 300-500 units per mg protein. Unit Definition: One unit will hydrolyze 1.0 μ mole of p- nitrophenyl phosphate per min at pH 10.4 at 37°C. Avidin, 2, 3-Dihydroxypropylfluorescein Isothiocyanate (Sigma A8409) Lyophilized powder containing approx. 90% protein; balance primarily sodium citrate buffer salts. Contains approx. 3 moles FITC per mole hydroxypropyl avidin. Avidin-Ferritin Labeled (Sigma A5405) Lyophilized powder. Approx. 30% protein; balance primarily tris buffer salt. Labeled with equine spleen ferritin. Actual ferritin to avidin ratio given on label. Avidin-FITC Labeled (Sigma A2901) Lyophilized powder containing approx. 80% protein (A 280 ); balance primarily sodium citrate. Approx. 3 moles of fluorescein isothiocyanate per mole of avidin. Avidin-fϊ-Galactosidase Labeled (Sigma A2930) Lyophilized powder containing approx. 50% protein (E 280 ); balance primarily Tris-succinate with a trace of dithiothreitol. Prepared from avidin (A 9275), partially acetylated, and f>-galactosidase (G 5635). Contains 1 to 3 moles avidin per mole galactosidase. Galactosidase Activity: 100-400 units per mg protein. Avidin Activity: 2-4 units per mg protein. - 13 - Unit Definition: One unit will hydrolyze 1.0 μ mole of o-nitrophenyl β-ό-galactoside per min, at pH 7.3 at 37°C. Avidin-Peroxidase Labeled (Sigma A3151) Labeled with Type VI peroxidase. Lyophilized powder containing approx. 80% protein (E280); balance primarily citrate buffer. Contains 0.7-2.0 moles peroxidase per mole avidin. Avidin Activity: 5-10 units per mg protein. Peroxidase Activity: 50-150 units per mg protein. Unit Definition: One unit will form 1 mg of purpurogallin in 20 sec from pyrogallol at pH 6.0 at 20°C. Avidin-Rhodamine Isothiocyanate Labeled (Sigma A3026) Lyophilized powder containing approx. 90% protein (Biuret); balance primarily citrate buffer salts. Contains 1-2 moles of rhodamine isothiocyanate per mole of avidin. Avidin, Succinylfluorescein Isothiocyanate (Sigma A8534) Lyophilized powder containing approx. 90% protein (Biuret); balance primarily sodium citrate buffer salts. Contains 2 to 4 moles FITC per mole succinyl-avidin. Avidin, Succinyl-Gold Labeled Avidin (Sigma A 9275), succinylated to reduce nonspecific interaction, adsorbed to colloidal gold for detection of biotinylated compounds. Suspension in 50% glycerol containing 0.01 M Tris buffer, 0.15 M NaCl, 0.02% PEG 20 and 0.02% sodium azide, pH 7.0. Concentration: A 5 , 0 approx. 5.0 - 14 - Having described the choices of enzyme conjugates available, the detailed procedure is now set forth for a DNA analysis. A. Covalently bind receptor to plate surface. 1. Prepare a solution of 3 μg/ml of avidin or streptavidin in carbonate buffer at pH-9.6. Add to wells; 2. Incubate for three hours at 37°C or overnight at room temperature; and, 3. Wash plate with tris buffer or phosphate buffer 3 times to remove unbound material. B. Block unreacted sites. 1. Prepare a solution of 3% BSA in PBS buffer pH=7.2; 2. Add to wells and incubate for 3 hours at 37°C or overnight at room temperature. 3. Wash three times with PBS buffer to remove unbound material; 4. Prepare a solution of 500 μg/ml of denatured salmon sperm DNA in 10XSSC buffer; 5. Add to wells and incubate 3 hours at 37°C; and, 6. Wash 3 times with 10XSSC buffer to remove unbound material. C. Prepare the sensitized 1st probe. 1. React the oligonucleotide complement to the target DNA with the appropriate biotinylating reagent such as photobiotin. D. React the sensitized probe to the prepared blocked plate. 1. Transfer the sensitized probe to PBS buffer at 3 μg/ml concentration; - 15 - 2. Add to wells and incubate 30 minutes at room temperature; and, 3. Wash three times with PBS buffer to remove unreacted probe. E. Hybridize the target. 1. Add solution containing the target DNA to the wells and react for 1 hours at 37°C; and, 2. Wash 3 times with PBS to remove unreacted material. F. Block the unreacted biotin. 1. Prepare a solution of 3 μg/ml of streptavidin in PBS; 2. Add to the wells and incubate for 30 minutes at room temperature. This blocks any biotin sites that have not reacted with streptavidin on the plates; and, 3. Wash wells three times with PBS to remove unreacted material. G. Prepare the sensitized second probe. 1. Repeat step 3 with the complement to another section of the target DNA. H. React the 2nd probe to the immobilized target. 1. Transfer the sensitized probe to PBS buffer at 3 μg/ml concentration; 2. Add to the wells and incubate for 30 minutes at room temperature. 3. Wash 3 times with PBS to remove unreacted material. - 16 - I. Add the detection system. 1- Prepare a solution of avidin-alkaline phosphatase conjugate in PBS at 3 μg/ml; 2. Add to the wells and allow to react for 30 minutes at room temperature; 3. Wash 3 times with PBS to remove unreacted material; 4. Add substrate (nitrophenyl phosphate); and, 5. Stop reaction after color develops with NaOH. J. Read the results with a standard plate reader. Alternative Procedure Steps A-C same as above. D. Hybridizatio . 1. Mix the sensitized probe with the solution containing the target DNA. Allow to hybridize for 30 minutes; and, 2. Add the solution to the wells; the avidin-biotin reaction will occur, immobilizing the hybridization product to the plate. Continue with step F above. Second Alternative Procedure Steps A-E same as above. Omit G. Prepare the sensitized second probe. 1. Sulfonate the DNA; 2. Transfer to lOXSSC buffer at 1 ti /ml concentration. - 17 - H. React the second probe to the immobilized target. 1. Add to the wells and allow hybridization to occur for 30 minutes at 37°C; 2. Wash 3 times with PBS to remove unreacted material. 1. Add the detection system. 1. Add the monoclonal antibody to sulfonated DNA at a concentration of 1 μg/ml; 2. Allow to react 1 hour at 37°C; 3. Wash 3 times with PBS to remove unreacted material; 4. Add polyclonal antibody-alkaline phosphatase conjugate directed against the monoclonal antibody; 5. Allow to react for 1 hour at 37°; 6. Wash 3 times with PBS to remove unreacted material; 7. Add substrate (nitrophenyl phosphate); and, 8. Stop reaction after color develops with NaOH. J. Read the results with a standard plate reader. Other variations 1. Use the monoclonal on the plate, sulfonate the first probe and use the avidin-biotin detection system; 2. Use horseradish peroxidase as the enzyme with an appropriate substrate; 3. Use another sensitizer-receptor system with either avidin-biotin detection, sulfonated monoclonal detection and any suitable enzyme-substrate combination; and, 4. Use a radioactive or fluorescent detection system or a luminescent detection system. - 18 - Method of Liquid Phase Quantitative Analysis Referring now to FIGS. 2 and 3, an assay plate prepared with masked receptor sites as described hereinabove is used for liquid phase quantitative analysis by the following steps: 1. Sensitizing a ligating polynucleotide (DNA) probe, said ligating DNA probe being complementary to a first portion of the target oligonucleotide and being attachable to the receptor site; 2. Attaching the ligating DNA probe to the receptor sites; 3. Hybridizing the denatured target oligonucleotide to the complementary portion of the ligating DNA probe; 4. Labeling a polynucleotide (DNA) probe with an enzyme conjugate and thereby forming a labeled DNA probe, said labeled DNA probe being complementary to a second portion of the target oligonucleotide; 5. Hybridizing the denatured target oligonucleotide to the complementary portion of the labeled DNA probe; 6. Adding a substrate to react with the enzyme conjugate of the labeled DNA probe and then a reagent to fix the label development at a desired point; 7. Reading the intensity of the label and calibrating the readout to indicate the quantity of target oligonucleotide present. With the steps of the quantitative analysis method generally set forth above, the various steps are now elaborated by reference to the Detailed Procedure and the schematic diagrams. Where the first or ligating probe is used with an avidin or streptavidin receptor, the probe is biotinylated by the procedure hereinabove provided. Where the first or ligating probe is used with a receptor of a monoclonal antibody against sulfonated DNA, the DNA probe is treated correspondingly by sulfonation. Referring to the - 19 - schematic diagrams of FIGS. 2 and FIG. 3, the exemplary avidin receptor sites are shown with the masking layers thereabout. In FIG. 3, attention is drawn to the first probe with the biotin portion thereof attached to the avidin receptor; to the first probe with the complementary portion of the target DNA; and to the second probe with the complementary portion thereof hybridized to the second complementary portion of the target DNA. The schematic diagram also shows the labeling enzyme conjugate attached to the second probe. Here, the example of an avidin-alkaline phosphatase conjugate and a nitrophenyl phosphate substrate is used. Any of a variety of microwell plate readers are commercially available. Typical of the instruments available is the Sigma Chemical Co. Bichromatic Photometer, Catalog No. M6280, a microwell plate reader for enzyme immunoassay testing. This instrument may be used with any microwell plate. Examples Examples for the purposes of this invention are provided hereinbelow: Example 1 Preparation of Streptavidin Coated Plate A solution of 3 μg/ml. of streptavidin in carbonate buffer (pH=9.6) was placed in the wells of a Xenobind Covalent Binding Plate (Cat. No. XPL 050 00) and incubated for 3 hours at 37°C. The plate was then washed 3 times with PBS buffer (pH=7.0) and then incubated 3 hours with a 3% BSA in PBS solution (pH=7.0) at 37°C. The plate was then washed 3 times with PBS (pH=7. 0) to remove any unbound BSA. The plate was next incubated for two hours with a solution of 500 μg/ml of denatured salmon sperm DNA in 10X SSC at room temperature. The plate was washed three times with 10X SSC to remove unbound DNA. The plate was tested for unblocked - 20 - binding sites by reacting it with a solution of 3 μg/ml of avidinalkaline phosphatase for three hours at 37°C and then washed three times with PBS buffer. A lOmM solution of p- nitrophenyl phosphate was incubated in the wells for 2 hours at 37°C. No color developed, indicating that there were no unblocked sites. A second plate was tested with a sulfonated DNA prepared from one fragment of a Hindlll digest using the Sigma Chem-Probe kit. The plate was then reacted with a monoclonal antibody to sulfonated DNA, a polyclonal antibody to the monoclonal conjugated to alkaline phosphatase and after washing with PBS 3 times, with a lOmM solution of p-nitrophenyl phosphate. No color developed. Example 2 A prepared blocked plate was reacted with a biotinylated Hind III DNA probe (0.05 μg/ml in 10X SSC) for 1 hour at room temperature and then washed three times with 10X SSC. The complementary DNA (0.1 μg/ml) was added as the target and hybridized for 1 hour at 42°C and then washed three times with 10X SSC to remove unhybridized DNA. A sulfonated Hind III DNA fragment, complementary to the target was hybridized at 420 for one hour and then the plate was washed 3 times with 10X SSC. The plate was then reacted with the monoclonal-polyclonal antibody system described in example one and the color was developed with p-NPP. The optical density was measured on a standard plate reader at 405nm. The OD was 0.150. Example 3 A prepared blocked plate was reacted as in example 2, but the target concentration was 0.15 μg/ml. The OD was 0.223. - 21 - Example 4 A prepared blocked plate was reacted with a biotinylated plasmid DNA PUC 119 at 0.05 μg/ml in 10X SSC for 1 hour at room temperature. After washing 3 times with 10X SSC it was reacted with a complementary plasmid DNA at 1 μg/ml in 10X SSC at 42°C for 1 hour. The plate was washed again three times with 10X SSC and then reacted with a second biotinylated plasmid probe at 0.1 μg/ml for 1 hour at 42°C. The plate was washed again with 10 X SSC and then incubated with avidin-alkaline phosphatase conjugate (0.2 μg/ml in blocking buffer) for 30 minutes at room temperature. The unbound conjugate was washed from the plate and the color developed with lOmM p-nitrophenyl phosphate for 30 minutes at 37°C. The color was measured at 405 nm on a standard plate reader. The OD was 1.8. Assay Kits The present invention lends itself readily to the preparation of kits having ELONA microwell plates or similar devices and the necessary buffers and reagents for oligonucleotide liquid phase quantitative analysis. A kit can contain the components required to biotinylate the oligonucleotide probe. Also, the kits can contain the components required after the probe is attached to the plate and to the target oligonucleotide, for labelling the second DNA probe developing the color, and arresting color development. The ELONA kit includes a microwell plate with streptavidin covalently attached to the surface thereof and the streptavidin is suitably masked to eliminate the binding of unwanted material directly to the interstitial areas of the plate. Thus there are no random, unmasked sites for the covalent binding of protein or DNA. - 22 - A researcher scientist will have all the components needed to carry out the assay. The Xenoprobe ELONA kit contains an, avidin coated blocked plate, biotinylating reagent, streptavidin, streptavidin-alkaline phosphatase conjugate, substrate, and stopping solution. A diagnostic test manufacturer can supply the probes already biotinylated with the first probe already reacted to the plate and with the unused biotin sites already blocked. The user has only to add his sample and the second probe, followed by the enzyme conjugate and substrate to obtain a quantitative measure of the concentration of the specific DNA in the sample. Because many varying and different embodiments may be made within the scope of the inventive concept herein taught, and because many modifications may be made in the embodiments herein detailed in accordance with the descriptive requirement of the law, it is to be understood that the details herein are to be interpreted as illustrative and not in a limiting sense.

Claims: - 23 - CLAIMS 1. A device for use in an oligonucleotide assay having predetermined portions of the surface thereof treated for covalent binding, said device comprising, in combination: a. a receptor material disposed upon and covalently bound to the treated predetermined portions, said receptor material partially covering said treated portions and leaving uncovered interstices therebetween of the surface treated for covalent binding; and, b. masking means for masking the uncovered interstices of surface treated for covalent binding, said masking means substantially covering and bound to the uncovered interstices without interfering with the receptor material. 2. A device as claimed in Claim 1 wherein said masking means further comprises: first masking means for masking the interstitial exposed surface, said first masking means substantially covering and bound to the interstitial exposed surface without interfering with the receptor material and leaving uncovered and small interstices therebetween of said exposed surface treated for covalent binding; and, second masking means for further masking the interstitial exposed surface, said second masking means substantially sealing said first masking means and bound to the small interstitial exposed surface without interfering with the receptor material. 3. A device as claimed in Claim 2 wherein said first masking means is selected from the group consisting of bovine serum albumin and milk protein and said second masking means is salmon sperm deoxyribonucleic acid. - 24 - . A device as claimed in Claim 1 further comprising a base with an array of wells therein, each said well having an exposed surface treated for covalent binding. 5. A device as claimed in Claim 4 wherein said base is constructed from a material selected from a group consisting of nylon, polycarbonate, polymethylmethacrylate, polystyrene, polytetrafluoroethylene and polyurethane. 6. A device as claimed in Claim 5 wherein said base is polystyrene. 7. A device as claimed in Claim 6 wherein the receptor material is a glycoprotein. 8. A device as claimed in Claim 7 wherein the glycoprotein is selected from the group consisting of avidin, streptavidin, and monoclonal antibody against sulfonated deoxyribonucleic acid. 9. A polystyrene body for use in an oligonucleotide assay having predetermined portions of an exposed surface thereof treated for covalent binding, said polystyrene body comprising: a. a receptor material disposed upon and covalently bound to said treated portions of said exposed surface, said receptor material partially covering said treated portions and leaving uncovered interstices therebetween of treated portions of said exposed surface for covalent binding; and, b. masking means for masking the interstitial treated portions of said exposed surface, said masking means substantially covering and bound to the interstitial exposed surface without interfering with the receptor material. 10. A polystyrene body as claimed in Claim 9 wherein said masking means, in turn, comprises: first masking means for masking the interstitial exposed surface, said first masking means substantially covering and bound to the interstitial exposed surface without interfering with the receptor material and leaving uncovered and small interstices therebetween of said exposed surface treated for covalent binding; and, second masking means for further masking the interstitial exposed surface, said second masking means substantially sealing said first masking means and bound to the small interstices of the exposed surface without interfering with the receptor material. 11. A polystyrene body as claimed in Claim 10 wherein the receptor material is a glycoprotein. 12. A polystyrene body as claimed in Claim 11 wherein the glycoprotein is selected from the group consisting of avidin, streptavidin, and monoclonal antibody against sulfonated DNA. 13. A polystyrene body as claimed in Claim 10 wherein said first masking means is bovine serum albumin and said second masking means is salmon sperm deoxyribonucleic acid. 14. A polystyrene body as claimed in Claim 9 wherein said body is a plate-like base. 15. A polystyrene body as claimed in Claim 14 wherein said base has a plurality of wells arrayed therein. 16. A polystyrene body as claimed in Claim 15 wherein the predetermined portions treated for covalent binding are the surfaces of said wells. 17. A polystyrene body as claimed in Claim 9 wherein said body is in a bead-like form. 18. A polystyrene body as claimed in Claim 18 wherein the predetermined portions treated for covalent binding are on the surface thereof. 19. A polystyrene body as claimed in Claim 17 wherein said bead-like form is an engineered particulate bead means for enhancing high-performance liquid chromatography, said bead means having channels therethrough. 20. A polystyrene body as claimed in Claim 19 wherein the predetermined portions treated for covalent binding are on the surface thereof. 21. A polystyrene body as claimed in Claim 9 wherein said body is a stick-like base. 22. A polystyrene body as claimed in Claim 21 wherein the predetermined portions treated for covalent binding are the surfaces of said wells. 23. A method of preparing an oligonucleotide assay plate from a covalent binding plate having an array of wells comprising the steps of: a. binding the receptor to said wells of said covalent binding plate by the substeps of: 1. disposing a solution of the receptor into the wells; 2. incubating the device to enhance receptor deposition for a predetermined time; 3. removing the unbound-after-incubation portion of the solution of the receptor by washing with a suitable buffer and thereby exposing a portion of the treated surface of the covalent binding plate; and, b. masking the exposed treated surface of the covalent binding plate, by the substeps of: 1. disposing a first solution of mask material on the exposed treated surface of the covalent binding plate; 2. incubating the device to enhance mask material deposition for a predetermined time; - 27 - 3. removing the unbound-after-incubation portion of said first solution of mask material by washing with a suitable buffer. 24. A method of Claim 23 wherein the receptor material is a glycoprotein. 25. A method of Claim 24 wherein the glycoprotein is selected from the group consisting of avidin, streptavidin, and monoclonal antibody against sulfonated deoxyribonucleic acid. 26. A method of Claim 23 wherein said first solution of mask material is bovine serum albumin. 27. A method of Claim 23 which further comprises the step of: c. further masking the exposed treated surface of the covalent binding plate, by the substeps of: 1. disposing a second solution of mask material on the exposed treated surface of the covalent binding plate; 2. incubating the device to enhance mask material deposition for a predetermined time; 3. removing the unbound-after-incubation portion of said second solution of mask material by washing with a suitable buffer. 28. A method of Claim 27 wherein the receptor material is a glycoprotein. 29. A method of Claim 28 wherein the glycoprotein is selected from the group consisting of avidin, streptavidin, and monoclonal antibody against sulfonated deoxyribonucleic acid. 30. A method of Claim 29 wherein the receptor material is streptavidin. 31. A method of Claim 27 wherein said first masking means is bovine serum albumin and said second masking means is salmon sperm deoxyribonucleic acid.

Inventors: DOUGLAS ALLAN S, DOUGLAS, ALLAN, S.
Applicants: MESSULAM ALEC MOSES, XENOPORE CORP, MESSULAM, ALEC, MOSES, XENOPORE CORPORATION
Application year: 1992
Main classification: G01N33
IPC codes: C12Q1, C40B60